BPC-157 Cost Per Month: 2026 Price Breakdown

A research program consuming BPC-157 as a reference material typically budgets $60 to $250 per month, depending on assay throughput. At current market pricing, a 5 mg vial runs $18 to $45 and a 10 mg vial runs $32 to $75 from suppliers that publish batch-specific HPLC and mass spectrometry data. A ten-vial kit of 5 mg units lands between $180 and $400, which is where most single-investigator budgets sit — roughly $90 to $260 per month once you amortize a kit across a six-to-ten-week consumption cycle. Bulk quantities at 1 g run $900 to $2,400. Add $15 to $35 per shipment for cold-pack handling. The figure that actually moves your cost per milligram, though, is net peptide content — covered below.

What the monthly number is actually made of

Monthly cost is not one line item. Broken out, a representative bench budget looks like this:

Material: $180–$400 per 10-vial kit of 5 mg units, amortized over 6–10 weeks of use.
Cold-chain shipping: $15–$35 per shipment, more if you order in small batches instead of consolidating. Four small orders a year cost $60–$140 in freight that one consolidated order does not.
Independent verification: $120–$400 per assay if you send a sample to a contract lab for confirmatory HPLC or LC-MS. Labs doing regulated work often run this on every incoming lot; labs doing exploratory work run it on one lot in five.
Storage: a −20 °C laboratory freezer draws roughly 400–700 kWh per year. At a US commercial rate near $0.13/kWh that is $52–$91 annually, or $4–$8 per month, shared across everything in the box.
Loss: budget 2–4% for vial breakage, stopper failure, and lots quarantined on receipt for documentation problems.

The material line dominates, but the verification line is the one that varies most between a well-run program and a sloppy one — and it is the one that determines whether the material line was money spent or money wasted.

Net peptide content is why your real cost per milligram is higher than the label

This is the single most common accounting error in peptide procurement, and most pricing pages will never mention it.

A vial labeled "5 mg" almost always refers to gross mass in the vial, not mass of peptide. Synthetic peptides purified by reverse-phase HPLC come off the column as salts — typically trifluoroacetate — and lyophilized powder retains bound water. Counterion mass plus residual moisture commonly accounts for 15% to 30% of total vial mass. Net peptide content for a 15-residue sequence like BPC-157 frequently falls in the 70% to 85% range.

A $30 vial labeled 5 mg with 78% net peptide content costs $7.69 per milligram of actual peptide — not $6.00. Across a year of routine consumption, that gap is real money, and it is invisible unless the certificate of analysis reports net peptide content separately from purity.

Purity and net peptide content are different measurements answering different questions. Purity (chromatographic, area-percent by HPLC at 214 nm) tells you what fraction of the peptide-related material is your target sequence. Net peptide content (usually by amino acid analysis or nitrogen determination) tells you what fraction of the powder in the vial is peptide at all. A lot can be 99.2% pure and still be 72% peptide by mass. Suppliers that report only the first number are not lying; they are answering the cheaper question.

When you compare two suppliers on price per milligram, normalize both to net peptide. It routinely reverses the ranking. See our quality documentation for how these two figures appear on a certificate of analysis and which method produced each.

What documentation should accompany the price

Cost without documentation is not a low price, it is an unknown. A defensible lot record includes:

HPLC chromatogram for the specific lot, with the gradient, column, wavelength, and retention time stated — not a generic PDF reused across lots. Look for a stated purity threshold, commonly ≥98.0% area-percent.
Mass spectrometry confirmation against the theoretical monoisotopic mass. BPC-157 is a 15-residue sequence with a theoretical average molecular weight near 1419.5 Da; ESI-MS should confirm within roughly ±1 Da of theoretical.
Lot and batch traceability — a lot number on the vial that matches the certificate, matches the packing slip, and can be pulled from supplier records two years later.
Stated storage conditions and expiry: lyophilized material at −20 °C with a shelf life typically declared at 24 to 36 months from the manufacture date, not from your receipt date.
Appearance and residual solvent notes, plus water content by Karl Fischer when the supplier runs it.

A supplier charging $22 per 5 mg vial with a lot-specific chromatogram is a better buy than one charging $16 with a stock PDF, because the second one has moved the verification cost onto your budget at $120–$400 per assay.

When this is not worth buying

The honest cases where the monthly spend is wasted:

You have no cold storage. If material sits at ambient temperature between deliveries, the declared 24–36 month shelf life does not apply to your inventory and your stated expiry date is fiction. A reference material with an unknown thermal history is not a reference material. A −20 °C freezer with a monitored temperature log is a prerequisite, not an upgrade. Buying without one converts a $300 kit into $300 of undocumented powder.

Your throughput is under about 2 mg per month. Lyophilized material has a finite life once the lot is opened and handled, and small programs routinely discard more than they consume. If a 50 mg kit will outlive its expiry before you use half of it, the effective cost per milligram consumed can run two to three times the sticker price. Buy the smaller SKU, pay the higher unit price, and come out ahead.

You need GMP, USP-grade, or clinical-grade material. Research-grade reference material is not that, and no amount of purity data makes it that. Programs with regulatory obligations should be sourcing from a supplier with the corresponding quality system and paying 5 to 20 times these prices for it. Read research use only before assuming otherwise — this is a scope limit, not a disclaimer formality.

You are optimizing for the lowest listed price. Below roughly $12–$15 per 5 mg, the economics of solid-phase synthesis, HPLC purification, lyophilization, and per-lot analytical testing stop working. Something has been dropped — most often per-lot testing, replaced by testing one lot and reusing the certificate. That failure mode is undetectable from a product page and obvious from a lot-number cross-check.

You cannot use the material within its declared window. Consolidating orders saves $60–$140 a year in freight but only helps if the consolidated quantity gets consumed. Freight savings that push you past an expiry date are a net loss.

Your work does not depend on identity or purity. For a method-development run where you are tuning a gradient and any peptide of similar hydrophobicity will do, a fully documented lot is over-specified. Save the documented material for the runs where the result has to hold up.

Reducing cost without giving up traceability

Consolidate shipments. Two orders a year instead of six saves $60–$140 in cold-pack freight. Check shipping for current handling terms before planning a reorder cadence.
Match SKU size to actual consumption. The per-milligram discount on a 1 g order is meaningless if 400 mg expires unused.
Verify one lot in five rather than every lot — if your supplier's lot-specific documentation has held up on prior spot checks. At $120–$400 per confirmatory assay, that policy costs $300–$1,000 a year instead of $1,500–$5,000.
Ask for the retained-sample policy. Suppliers holding retains for 12–24 months can re-test a disputed lot; suppliers who do not, cannot, and a dispute becomes your word against theirs.
Volume tiers matter above roughly 10 g per year. At that scale, wholesale pricing typically improves per-milligram cost by 20–40% over list.

Track cost per milligram of net peptide from a documented lot, not cost per vial. It is a slightly worse-looking number and a far more useful one, and it is the only basis on which two suppliers can honestly be compared.